Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology

Baoying Liao, Jie Qiao, Yanli Pang, Baoying Liao, Jie Qiao, Yanli Pang

Abstract

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease. PCOS patients are characterized by hyperandrogenemia, anovulation, and metabolic dysfunction. Hypothalamus-pituitary-ovary axis imbalance is considered as an important pathophysiology underlying PCOS, indicating that central modulation, especially the abnormal activation of hypothalamic GnRH neurons plays a vital role in PCOS development. Increased GnRH pulse frequency can promote LH secretion, leading to ovarian dysfunction and abnormal sex steroids synthesis. By contrast, peripheral sex steroids can modulate the action of GnRH neurons through a feedback effect, which is impaired in PCOS, thus forming a vicious cycle. Additionally, hypothalamic GnRH neurons not only serve as the final output pathway of central control of reproductive axis, but also as the central connection point where reproductive function and metabolic state inter-regulate with each other. Metabolic factors, such as insulin resistance and obesity in PCOS patients can regulate GnRH neurons activity, and ultimately regulate reproductive function. Besides, gut hormones act on both brain and peripheral organs to modify metabolic state. Gut microbiota disturbance is also related to many metabolic diseases and has been reported to play an essential part in PCOS development. This review concludes with the mechanism of central modulation and the interaction between neuroendocrine factors and reproductive or metabolic disorders in PCOS development. Furthermore, the role of the gut microenvironment as an important part involved in the abnormal neuronal-reproductive-metabolic circuits that contribute to PCOS is discussed, thus offering possible central and peripheral therapeutic targets for PCOS patients.

Keywords: gut microbiota; hypothalamus–pituitary–ovary axis; metabolic disorders; ovarian dysfunction; polycystic ovary syndrome.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Liao, Qiao and Pang.

Figures

Figure 1
Figure 1
Central regulation of PCOS. Hypothalamic GnRH pulse mediates regulation of LH and FSH synthesis, which plays an important role in PCOS pathophysiology. This process is modulated by central regulators including KNDy neurons, POMC neurons, and neurotransmitters. In addition, peripheral factors including abnormal ovarian hormone levels, metabolic disorders, and gut microbiota dysbiosis also contribute to PCOS development by acting on their receptors expressed in hypothalamic neurons. Moreover, central regulators and peripheral factors interact with each other and form an abnormal neuronal–reproductive–metabolic circuit, thus promoting PCOS development. GnRH, Gonadotropin-releasing hormone; KNDy neurons, kisspeptin/NKB/dynorphin A neurons; POMC neurons, Pro-opiomelanocortin neurons; GABA, γ-aminobutyric acid; GLP-1, Glucagon-like peptide-1; IR, Insulin receptor; LepR, Leptin receptor; AR, Androgen receptor; GLP-1R, Glucagon-like peptide-1 receptor; AMHR, Anti-Müllerian hormone receptor; LH, Luteinizing hormone; FSH, Follicle stimulating hormone; AMH, Anti-Müllerian hormone; SHBG, Sex hormone-binding globulin; IL-22, Interleukin 22; SCFAs, Short-chain fatty acids.

References

    1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic Ovary Syndrome. Lancet (2007) 370(9588):685–97. 10.1016/S0140-6736(07)61345-2
    1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. . Polycystic Ovary Syndrome. Nat Rev Dis Primers (2016) 2:16057. 10.1038/nrdp.2016.57
    1. Jayasena CN, Franks S. The Management of Patients With Polycystic Ovary Syndrome. Nat Rev Endocrinol (2014) 10(10):624–36. 10.1038/nrendo.2014.102
    1. McAllister JM, Legro RS, Modi BP, Strauss JF, 3rd. Functional Genomics of PCOS: From GWAS to Molecular Mechanisms. Trends Endocrinol Metab (2015) 26(3):118–24. 10.1016/j.tem.2014.12.004
    1. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. . Genome-Wide Association Study Identifies Eight New Risk Loci for Polycystic Ovary Syndrome. Nat Genet (2012) 44(9):1020–5. 10.1038/ng.2384
    1. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 36(5):487–525. 10.1210/er.2015-1018
    1. Abbott DH, Nicol LE, Levine JE, Xu N, Goodarzi MO, Dumesic DA. Nonhuman Primate Models of Polycystic Ovary Syndrome. Mol Cell Endocrinol (2013) 373(1-2):21–8. 10.1016/j.mce.2013.01.013
    1. Thackray VG. Sex, Microbes, and Polycystic Ovary Syndrome. Trends Endocrinol Metab (2019) 30(1):54–65. 10.1016/j.tem.2018.11.001
    1. Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, et al. . Gut Microbiota-Bile Acid-Interleukin-22 Axis Orchestrates Polycystic Ovary Syndrome. Nat Med (2019) 25(8):1225–33. 10.1038/s41591-019-0509-0
    1. Qi X, Yun C, Liao B, Qiao J, Pang Y. The Therapeutic Effect of interleukin-22 in High Androgen-Induced Polycystic Ovary Syndrome. J Endocrinol (2020) 245(2):281–9. 10.1530/JOE-19-0589
    1. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of Androstenedione by Isolated Thecal Cells From Polycystic Ovaries. J Clin Endocrinol Metab (1994) 79(4):1158–65. 10.1210/jc.79.4.1158
    1. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. . Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab (1997) 82(7):2248–56. 10.1210/jcem.82.7.4105
    1. Cara JF, Fan J, Azzarello J, Rosenfield RL. Insulin-Like Growth Factor-I Enhances Luteinizing Hormone Binding to Rat Ovarian Theca-Interstitial Cells. J Clin Invest (1990) 86(2):560–5. 10.1172/JCI114745
    1. Herbison AE. Control of Puberty Onset and Fertility by Gonadotropin-Releasing Hormone Neurons. Nat Rev Endocrinol (2016) 12(8):452–66. 10.1038/nrendo.2016.70
    1. Aparicio SA. Kisspeptins and GPR54–the New Biology of the Mammalian GnRH Axis. Cell Metab (2005) 1(5):293–6. 10.1016/j.cmet.2005.04.001
    1. Zhang C, Bosch MA, Qiu J, Ronnekleiv OK, Kelly MJ. 17beta-Estradiol Increases Persistent Na(+) Current and Excitability of AVPV/PeN Kiss1 Neurons in Female Mice. Mol Endocrinol (2015) 29(4):518–27. 10.1210/me.2014-1392
    1. Kauffman AS, Clifton DK, Steiner RA. Emerging Ideas About Kisspeptin- Gpr54 Signaling in the Neuroendocrine Regulation of Reproduction. Trends Neurosci (2007) 30(10):504–11. 10.1016/j.tins.2007.08.001
    1. Cheng G, Coolen LM, Padmanabhan V, Goodman RL, Lehman MN. The Kisspeptin/Neurokinin B/Dynorphin (Kndy) Cell Population of the Arcuate Nucleus: Sex Differences and Effects of Prenatal Testosterone in Sheep. Endocrinology (2010) 151(1):301–11. 10.1210/en.2009-0541
    1. Tang R, Ding X, Zhu J. Kisspeptin and Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) (2019) 10:298. 10.3389/fendo.2019.00298
    1. Navarro VM. Metabolic Regulation of Kisspeptin - the Link Between Energy Balance and Reproduction. Nat Rev Endocrinol (2020) 16(8):407–20. 10.1038/s41574-020-0363-7
    1. Esparza LA, Schafer D, Ho BS, Thackray VG, Kauffman AS. Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model. Endocrinology (2020) 161(4):1–15. 10.1210/endocr/bqaa018
    1. Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, et al. . Plasma Metastin Levels are Negatively Correlated With Insulin Resistance and Free Androgens in Women With Polycystic Ovary Syndrome. Fertil Steril (2006) 85(6):1778–83. 10.1016/j.fertnstert.2005.11.044
    1. Hill JW, Elias CF, Fukuda M, Williams KW, Berglund ED, Holland WL, et al. . Direct Insulin and Leptin Action on Pro-Opiomelanocortin Neurons is Required for Normal Glucose Homeostasis and Fertility. Cell Metab (2010) 11(4):286–97. 10.1016/j.cmet.2010.03.002
    1. Gaytan F, Gaytan M, Castellano JM, Romero M, Roa J, Aparicio B, et al. . KiSS-1 in the Mammalian Ovary: Distribution of Kisspeptin in Human and Marmoset and Alterations in KiSS-1 Mrna Levels in a Rat Model of Ovulatory Dysfunction. Am J Physiol Endocrinol Metab (2009) 296(3):E520–31. 10.1152/ajpendo.90895.2008
    1. Qi X, Salem M, Zhou W, Sato-Shimizu M, Ye G, Smitz J, et al. . Neurokinin B Exerts Direct Effects on the Ovary to Stimulate Estradiol Production. Endocrinology (2016) 157(9):3355–65. 10.1210/en.2016-1354
    1. Blasco V, Pinto FM, Fernandez-Atucha A, Gonzalez-Ravina C, Fernandez-Sanchez M, Candenas L. Female Infertility is Associated With an Altered Expression of the Neurokinin B/Neurokinin B Receptor and Kisspeptin/Kisspeptin Receptor Systems in Ovarian Granulosa and Cumulus Cells. Fertility Sterility (2020) 114(4):869–78. 10.1016/j.fertnstert.2020.05.006
    1. Blasco V, Pinto FM, Fernandez-Atucha A, Prados N, Tena-Sempere M, Fernandez-Sanchez M, et al. . Altered Expression of the Kisspeptin/KISS1R and Neurokinin B/Nk3r Systems in Mural Granulosa and Cumulus Cells of Patients With Polycystic Ovarian Syndrome. J Assist Reprod Genet (2019) 36(1):113–20. 10.1007/s10815-018-1338-7
    1. Fang P, Yu M, Shi M, Bo P, Zhang Z. Galanin Peptide Family Regulation of Glucose Metabolism. Front Neuroendocrinol (2020) 56:100801. 10.1016/j.yfrne.2019.100801
    1. Azin F, Khazali H. Neuropeptide Galanin and its Effects on Metabolic and Reproductive Disturbances in Female Rats With Estradiol Valerate (Ev) - Induced Polycystic Ovary Syndrome (Pcos). Neuropeptides (2020) 80:102026. 10.1016/j.npep.2020.102026
    1. Altinkaya SO. Galanin and Glypican-4 Levels Depending on Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome. Arch Endocrinol Metab (2021). 10.20945/2359-3997000000340
    1. Ilie IR. Neurotransmitter, Neuropeptide and Gut Peptide Profile in PCOS-pathways Contributing to the Pathophysiology, Food Intake and Psychiatric Manifestations of PCOS. Adv Clin Chem (2020) 96:85–135. 10.1016/bs.acc.2019.11.004
    1. Silva MSB, Desroziers E, Hessler S, Prescott M, Coyle C, Herbison AE, et al. . Activation of Arcuate Nucleus GABA Neurons Promotes Luteinizing Hormone Secretion and Reproductive Dysfunction: Implications for Polycystic Ovary Syndrome. Ebiomedicine (2019) 44:582–96. 10.1016/j.ebiom.2019.05.065
    1. Porter DT, Moore AM, Cobern JA, Padmanabhan V, Goodman RL, Coolen LM, et al. . Prenatal Testosterone Exposure Alters Gabaergic Synaptic Inputs to GnRH and KNDy Neurons in a Sheep Model of Polycystic Ovarian Syndrome. Endocrinology (2019) 160(11):2529–42. 10.1210/en.2019-00137
    1. Richards JS, Liu Z, Kawai T, Tabata K, Watanabe H, Suresh D, et al. . Adiponectin and its Receptors Modulate Granulosa Cell and Cumulus Cell Functions, Fertility, and Early Embryo Development in the Mouse and Human. Fertil Steril (2012) 98(2):471–9 e1. 10.1016/j.fertnstert.2012.04.050
    1. Moore AM, Prescott M, Marshall CJ, Yip SH, Campbell RE. Enhancement of a Robust Arcuate GABAergic Input to Gonadotropin-Releasing Hormone Neurons in a Model of Polycystic Ovarian Syndrome. Proc Natl Acad Sci U S A (2015) 112(2):596–601. 10.1073/pnas.1415038112
    1. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. . Granulosa Cell Production of Anti-Mullerian Hormone is Increased in Polycystic Ovaries. J Clin Endocrinol Metab (2007) 92(1):240–5. 10.1210/jc.2006-1582
    1. Walters KA. Role of Androgens in Normal and Pathological Ovarian Function. Reproduction (2015) 149(4):R193–218. 10.1530/REP-14-0517
    1. Sullivan SD, Moenter SM. Gabaergic Integration of Progesterone and Androgen Feedback to Gonadotropin-Releasing Hormone Neurons. Biol Reprod (2005) 72(1):33–41. 10.1095/biolreprod.104.033126
    1. Cheng XB, Jimenez M, Desai R, Middleton LJ, Joseph SR, Ning G, et al. . Characterizing the Neuroendocrine and Ovarian Defects of Androgen Receptor-Knockout Female Mice. Am J Physiol Endocrinol Metab (2013) 305(6):E717–26. 10.1152/ajpendo.00263.2013
    1. Walters KA, Edwards MC, Tesic D, Caldwell ASL, Jimenez M, Smith JT, et al. . The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis. Neuroendocrinology (2018) 106(4):389–400. 10.1159/000487762
    1. Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S. Increased Anti-Mullerian Hormone and Decreased Fsh Levels in Follicular Fluid Obtained in Women With Polycystic Ovaries at the Time of Follicle Puncture for In Vitro Fertilization. Fertil Steril (2010) 94(1):198–204. 10.1016/j.fertnstert.2009.03.004
    1. Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. . Anti-Mullerian Hormone Reduces Follicle Sensitivity to Follicle-Stimulating Hormone in Human Granulosa Cells. Fertil Steril (2011) 96(5):1246–51.e1. 10.1016/j.fertnstert.2011.08.015
    1. Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. . Novel Role for Anti-Mullerian Hormone in the Regulation of GnRH Neuron Excitability and Hormone Secretion. Nat Commun (2016) 7:10055. 10.1038/ncomms10055
    1. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, et al. . A Novel Member of the Transmembrane Serine/Threonine Kinase Receptor Family is Specifically Expressed in the Gonads and in Mesenchymal Cells Adjacent to the Mullerian Duct. Development (1994) 120(1):189–97. 10.1242/dev.120.1.189
    1. Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, et al. . Elevated Prenatal Anti-Mullerian Hormone Reprograms the Fetus and Induces Polycystic Ovary Syndrome in Adulthood. Nat Med (2018) 24(6):834–46. 10.1038/s41591-018-0035-5
    1. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells From Women With Polycystic Ovary Syndrome by Activating its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System. J Clin Endocrinol Metab (1998) 83(6):2001–5. 10.1210/jcem.83.6.4886
    1. Adashi EY, Hsueh AJ, Yen SS. Insulin Enhancement of Luteinizing Hormone and Follicle-Stimulating Hormone Release by Cultured Pituitary Cells. Endocrinology (1981) 108(4):1441–9. 10.1210/endo-108-4-1441
    1. Yadav A, Kataria MA, Saini V, Yadav A. Role of Leptin and Adiponectin in Insulin Resistance. Clin Chim Acta (2013) 417:80–4. 10.1016/j.cca.2012.12.007
    1. Konner AC, Bruning JC. Selective Insulin and Leptin Resistance in Metabolic Disorders. Cell Metab (2012) 16(2):144–52. 10.1016/j.cmet.2012.07.004
    1. Zheng SH, Du DF, Li XL. Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis. Reprod Sci (2017) 24(5):656–70. 10.1177/1933719116670265
    1. Pehlivanov B, Mitkov M. Serum Leptin Levels Correlate With Clinical and Biochemical Indices of Insulin Resistance in Women With Polycystic Ovary Syndrome. Eur J Contracept Reprod Health Care (2009) 14(2):153–9. 10.1080/13625180802549962
    1. Yan X, Yuan C, Zhao N, Cui Y, Liu J. Prenatal Androgen Excess Enhances Stimulation of the GNRH Pulse in Pubertal Female Rats. J Endocrinol (2014) 222(1):73–85. 10.1530/JOE-14-0021
    1. Escobar-Morreale HF, San Millan JL. Abdominal Adiposity and the Polycystic Ovary Syndrome. Trends Endocrinol Metab (2007) 18(7):266–72. 10.1016/j.tem.2007.07.003
    1. Zhao S, Zhu Y, Schultz RD, Li N, He Z, Zhang Z, et al. . Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy. Cell Metab (2019) 30(4):706–19 e6. 10.1016/j.cmet.2019.08.005
    1. Wen L, Lin W, Li Q, Chen G, Wen J. Effect of Sleeve Gastrectomy on Kisspeptin Expression in the Hypothalamus of Rats With Polycystic Ovary Syndrome. Obes (Silver Spring) (2020) 28(6):1117–28. 10.1002/oby.22795
    1. Araujo BS, Baracat MCP, Dos Santos Simoes R, de Oliveira Nunes C, Maciel GAR, Lobo RA, et al. . Kisspeptin Influence on Polycystic Ovary Syndrome-a Mini Review. Reprod Sci (2020) 27(2):455–60. 10.1007/s43032-019-00085-6
    1. Shorakae S, Lambert EA, Jona E, Ika Sari C, de Courten B, Dixon JB, et al. . Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome-A Randomized Controlled Trial. Front Physiol (2018) 9eeloc . 10.3389/fphys.2018.01486
    1. Larabee CM, Neely OC, Domingos AI. Obesity: A Neuroimmunometabolic Perspective. Nat Rev Endocrinol (2020) 16(1):30–43. 10.1038/s41574-019-0283-6
    1. Bohler H, Mokshagundam S, Winters SJ. Adipose Tissue and Reproduction in Women. Fertility Sterility (2010) 94(3):795–825. 10.1016/j.fertnstert.2009.03.079
    1. Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, et al. . Adiponectin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis. Hum Reprod Update (2009) 15(3):297–307. 10.1093/humupd/dmp006
    1. Shorakae S, Abell SK, Hiam DS, Lambert EA, Eikelis N, Jona E, et al. . High-Molecular-Weight Adiponectin is Inversely Associated With Sympathetic Activity in Polycystic Ovary Syndrome. Fertility Sterility (2018) 109(3):532–9. 10.1016/j.fertnstert.2017.11.020
    1. Heras V, Castellano JM, Fernandois D, Velasco I, Rodriguez-Vazquez E, Roa J, et al. . Central Ceramide Signaling Mediates Obesity-Induced Precocious Puberty. Cell Metab (2020) 32(6):6–8. 10.1016/j.cmet.2020.10.001
    1. Schroeder B, Backhed F. Signals From the Gut Microbiota to Distant Organs in Physiology and Disease. Nat Med (2016) 22(10):1079–89. 10.1038/nm.4185
    1. Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. . The Microbiota-Gut-Brain Axis. Physiol Rev (2019) 99(4):1877–2013. 10.1152/physrev.00018.2018
    1. Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of Single and Combined Treatment With Exenatide and Metformin on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome. J Clin Endocr Metab (2008) 93(7):2670–8. 10.1210/jc.2008-0115
    1. Nylander M, Frossing S, Clausen HV, Kistorp C, Faber J, Skouby SO. Effects of Liraglutide on Ovarian Dysfunction in Polycystic Ovary Syndrome: A Randomized Clinical Trial. Reprod BioMed Online (2017) 35(1):121–7. 10.1016/j.rbmo.2017.03.023
    1. Salamun V, Jensterle M, Janez A, Bokal EV. Liraglutide Increases Ivf Pregnancy Rates in Obese Pcos Women With Poor Response to First-Line Reproductive Treatments: A Pilot Randomized Study. Eur J Endocrinol (2018) 179(1):1–11. 10.1530/EJE-18-0175
    1. Outeirino-Iglesias V, Romani-Perez M, Gonzalez-Matias LC, Vigo E, Mallo F. Glp-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats. Endocrinology (2015) 156(11):4226–37. 10.1210/en.2014-1978
    1. Heppner KM, Baquero AF, Bennett CM, Lindsley SR, Kirigiti MA, Bennett B, et al. . Glp-1r Signaling Directly Activates Arcuate Nucleus Kisspeptin Action in Brain Slices But Does Not Rescue Luteinizing Hormone Inhibition in Ovariectomized Mice During Negative Energy Balance. eNeuro (2017) 4(1):ENEURO.0198-16.2016. 10.1523/ENEURO.0198-16.2016
    1. Farkas I, Vastagh C, Farkas E, Balint F, Skrapits K, Hrabovszky E, et al. . Glucagon-Like Peptide-1 Excites Firing and Increases Gabaergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (Gnrh) Neurons of the Male Mice Via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways. Front Cell Neurosci (2016) 10:214. 10.3389/fncel.2016.00214
    1. Whelan K, Efthymiou L, Judd PA, Preedy VR, Taylor MA. Appetite During Consumption of Enteral Formula as a Sole Source of Nutrition: The Effect of Supplementing Pea-Fibre and Fructo-Oligosaccharides. Br J Nutr (2006) 96(2):350–6. 10.1079/BJN20061791
    1. Archer BJ, Johnson SK, Devereux HM, Baxter AL. Effect of Fat Replacement by Inulin or Lupin-Kernel Fibre on Sausage Patty Acceptability, Post-Meal Perceptions of Satiety and Food Intake in Men. Br J Nutr (2004) 91(4):591–9. 10.1079/BJN20031088
    1. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, et al. . Effects of the Gut Microbiota on Host Adiposity are Modulated by the Short-Chain Fatty-Acid Binding G Protein-Coupled Receptor, Gpr41. Proc Natl Acad Sci U S A (2008) 105(43):16767–72. 10.1073/pnas.0808567105
    1. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. . Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion Via the G-protein-coupled Receptor Ffar2. Diabetes (2012) 61(2):364–71. 10.2337/db11-1019
    1. Nohr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, et al. . GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes. Endocrinology (2013) 154(10):3552–64. 10.1210/en.2013-1142
    1. Hwang I, Park YJ, Kim YR, Kim YN, Ka S, Lee HY, et al. . Alteration of Gut Microbiota by Vancomycin and Bacitracin Improves Insulin Resistance Via Glucagon-Like Peptide 1 in Diet-Induced Obesity. FASEB J (2015) 29(6):2397–411. 10.1096/fj.14-265983
    1. Strandwitz P. Neurotransmitter Modulation by the Gut Microbiota. Brain Res (2018) 1693(Pt B):128–33. 10.1016/j.brainres.2018.03.015
    1. Hassan AM, Mancano G, Kashofer K, Frohlich EE, Matak A, Mayerhofer R, et al. . High-Fat Diet Induces Depression-Like Behaviour in Mice Associated With Changes in Microbiome, Neuropeptide Y, and Brain Metabolome. Nutr Neurosci (2019) 22(12):877–93. 10.1080/1028415X.2018.1465713
    1. Liang Z, Di N, Li L, Yang D. Gut Microbiota Alterations Reveal Potential Gut-Brain Axis Changes in Polycystic Ovary Syndrome. J Endocrinol Invest (2021). 10.1007/s40618-020-01481-5
    1. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Communication. Nat Rev Gastroenterol Hepatol (2019) 16(8):461–78. 10.1038/s41575-019-0157-3
    1. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. . Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell (2016) 167(6):1469–80 e12. 10.1016/j.cell.2016.11.018
    1. Zhang JC, Sun ZH, Jiang SM, Bai XY, Ma CC, Peng QN, et al. . Probiotic Bifidobacterium Lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients Through the Gut-Brain Axis. Msystems (2019) 4(2):e00017–19. 10.1128/mSystems.00017-19
    1. Zhang BJ, Shen SM, Gu TW, Hong T, Liu JY, Sun J, et al. . Increased Circulating Conjugated Primary Bile Acids are Associated With Hyperandrogenism in Women With Polycystic Ovary Syndrome. J Steroid Biochem (2019) 189:171–5. 10.1016/j.jsbmb.2019.03.005
    1. Jayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML, et al. . The Effects of kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans. J Clin Endocrinol Metab (2011) 96(12):E1963–72. 10.1210/jc.2011-1408
    1. Narayanaswamy S, Jayasena CN, Ng N, Ratnasabapathy R, Prague JK, Papadopoulou D, et al. . Subcutaneous Infusion of Kisspeptin-54 Stimulates Gonadotrophin Release in Women and the Response Correlates With Basal Oestradiol Levels. Clin Endocrinol (Oxf) (2016) 84(6):939–45. 10.1111/cen.12977
    1. Ely BR, Francisco MA, Halliwill JR, Bryan SD, Comrada LN, Larson EA, et al. . Heat Therapy Reduces Sympathetic Activity and Improves Cardiovascular Risk Profile in Women Who are Obese With Polycystic Ovary Syndrome. Am J Physiol Regul Integr Comp Physiol (2019) 317(5):R630–40. 10.1152/ajpregu.00078.2019
    1. Maliqueo M, Benrick A, Alvi A, Johansson J, Sun M, Labrie F, et al. . Circulating Gonadotropins and Ovarian Adiponectin System are Modulated by Acupuncture Independently of Sex Steroid or Beta-Adrenergic Action in a Female Hyperandrogenic Rat Model of Polycystic Ovary Syndrome. Mol Cell Endocrinol (2015) 412:159–69. 10.1016/j.mce.2015.04.026
    1. Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al. . Akkermansia Muciniphila Secretes a Glucagon-Like Peptide-1-Inducing Protein That Improves Glucose Homeostasis and Ameliorates Metabolic Disease in Mice. Nat Microbiol (2021) 6(5):563–73. 10.1038/s41564-021-00880-5
    1. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. . Gut Bacteria Selectively Promoted by Dietary Fibers Alleviate Type 2 Diabetes. Science (2018) 359(6380):1151–6. 10.1126/science.aao5774
    1. Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, et al. . Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients. Clin Gastroenterol Hepatol (2020) 18(4):855–63.e2. 10.1016/j.cgh.2019.07.006
    1. Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, et al. . Probiotic Clostridium Butyricum Ameliorated Motor Deficits in a Mouse Model of Parkinson’s Disease Via Gut microbiota-GLP-1 Pathway. Brain Behav Immun (2021) 91:703–15. 10.1016/j.bbi.2020.10.014
    1. Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell (2018) 173(7):1728–41.e13. 10.1016/j.cell.2018.04.027
    1. Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. . The Gut Microbiome From Patients With Schizophrenia Modulates the Glutamate-Glutamine-GABA Cycle and Schizophrenia-Relevant Behaviors in Mice. Sci Adv (2019) 5(2):eaau8317. 10.1126/sciadv.aau8317
    1. Kootte RS, Levin E, Salojarvi J, Smits LP, Hartstra AV, Udayappan SD, et al. . Improvement of Insulin Sensitivity After Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab (2017) 26(4):611–9.e6. 10.1016/j.cmet.2017.09.008
    1. Chen L, Wang D, Garmaeva S, Kurilshikov A, Vich Vila A, Gacesa R, et al. . The Long-Term Genetic Stability and Individual Specificity of the Human Gut Microbiome. Cell (2021) 184(9):2302–15.e12. 10.2139/ssrn.3653563

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir